Compare Alcon AG (ALC) vs Caterpillar Inc (CAT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Caterpillar Inc — how do they compare? Alcon AG trades at $66.64 (market cap $32.69B), while Caterpillar Inc trades at $937.2 (market cap $433.01B). The key difference: Caterpillar Inc is far larger — about 13.2× Alcon AG's market cap, and Caterpillar Inc pays the higher dividend (0.69%). Which is the better fit depends on your goals.
| ALC | CAT | |
|---|---|---|
Market Cap | $32.69B | $433.01B |
Sector | Health | Industrials |
52-Week High | $92.22 | $1.06K |
52-Week Low | $62.02 | $394.29 |
Enterprise Value | $36.28B | $472.01B |
Dividend Yield | 0.54% | 0.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
Caterpillar (CAT) trades at $969.92, up 0.66% on the day and near its 52-week high, supported by strong earnings beats and bullish technical signals. The stock's valuation multiples are elevated with a P/E of 48.3 and P/S of 6.44, but robust profitability metrics like a 51.35% ROE and consistent dividend growth underscore fundamental strength. Recent news highlights CAT's exposure to AI-driven infrastructure demand, with the Power & Energy segment emerging as a key growth driver amid a record backlog.
Outlook remains positive given earnings momentum and analyst consensus, though high valuation and macroeconomic sensitivity pose risks. The stock offers growth from data center and infrastructure trends, but investors should weigh premium pricing against potential cyclical headwinds in industrial markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Caterpillar Inc
Caterpillar Inc. designs, manufactures, and markets construction, mining, and forestry machinery. The Company also manufactures engines and other related parts for its equipment, and offers financing and insurance. Caterpillar distributes its products through a worldwide organization of dealers.
Read more on CAT →
